Home / Resources / Regulatory resources

薬事規制

最新のリソース

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

The Do’s and Don’ts of Define.xml

The Do’s and Don’ts of Define.xml

How Model-informed drug development rescue projects from a risky situation

How Model-informed drug development rescue projects from a risky situation

注目コンテンツ

FDA ESG NextGen for Regulatory Submissions

FDA ESG NextGen for Regulatory Submissions

Upcoming regulatory webinars

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

2025年7月9日 – 11am ET

ウェビナー

Transform Your PK/PD Workflow with AI and the Cloud

2025年7月10日 – 11am ET

ウェビナー

Faster Mapping from Source Data to Target SDTM

July 15 – 11am ET & July 17 – 11am IST

Latest regulatory blogs

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

The Do’s and Don’ts of Define.xml

FDA ESG NextGen for Regulatory Submissions

CERTAINTY 2025: The power of Model-Informed Drug Development

SEND V4.0 – What to Expect and When to Expect It

Best Practices for AI Prompt Engineering in Life Sciences

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois

展示会・学会

ACoP 2025

October 18 - 21, 2025

All regulatory resources

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Blog

The Do’s and Don’ts of Define.xml

CDISC, Certara Products - Pinnacle 21, Define-XML, Blog

How Model-informed drug development rescue projects from a risky situation

Certara Services, Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Case Study

FDA ESG NextGen for Regulatory Submissions

Certara Products - GlobalSubmit, Blog

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Webinar

Faster Mapping from Source Data to Target SDTM

Certara Products - Pinnacle 21, Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Certara Products - Phoenix, Certara Products - Pinnacle 21, Certara Services, Clinical Pharmacology, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Webinar - Resources LP - Upcoming, Webinar

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

Cardiovascular, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Transform Your PK/PD Workflow with AI and the Cloud

Certara Products - Phoenix, Webinar - Resources LP - Upcoming, Webinar

PSI 2025 Conference

Certara Products, Certara Services, Conference LP - Latest, Conference

2025 Korea CDISC Day

Conference LP - Latest, Conference

1
2
3
…
28
›

ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software